CytomX Therapeutics (CTMX) Cash & Equivalents (2014 - 2026)
CytomX Therapeutics' Cash & Equivalents was $17.22 million in Q2 2026, down 64.9% from $49.04 million a year earlier and down 40.3% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Cash & Equivalents (2014 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at CytomX Therapeutics came in at $12.67 million, down 66.7% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -41.9% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $38.05 million in FY2024 (+121.6%), $17.17 million in FY2023 (-91.1%), $193.65 million in FY2022 (-5.8%) and $205.53 million in FY2021 (+7.1%).
- Quarterly Cash & Equivalents has moved between $12.67 million (Q4 2025) and $236.28 million (Q3 2021) over five years.
- Compared with a year earlier, Cash & Equivalents has declined for four straight quarters, with growth averaging 4.5% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2024 (growth of 121.6%); the worst was Q4 2023 (a decline of 91.1%).
- Per Business Quant data, CTMX's Cash & Equivalents in the three quarters before Q2 2026 was $28.83 million (Q1 2026), $12.67 million (Q4 2025) and $34.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | CytomX Therapeutics | 592.69 Mn | -364.98 Mn | - | 17.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.22 Mn |
| Mar 31, 2026 | 28.83 Mn |
| Dec 31, 2025 | 12.67 Mn |
| Sep 30, 2025 | 34.19 Mn |
| Jun 30, 2025 | 49.04 Mn |
| Mar 31, 2025 | 47.60 Mn |
| Dec 31, 2024 | 38.05 Mn |
| Sep 30, 2024 | 40.58 Mn |
| Jun 30, 2024 | 43.25 Mn |
| Mar 31, 2024 | 36.19 Mn |
| Dec 31, 2023 | 17.17 Mn |
| Sep 30, 2023 | 26.02 Mn |
| Jun 30, 2023 | 57.54 Mn |
| Mar 31, 2023 | 56.36 Mn |
| Dec 31, 2022 | 193.65 Mn |
| Sep 30, 2022 | 95.04 Mn |
| Jun 30, 2022 | 129.29 Mn |
| Mar 31, 2022 | 163.49 Mn |
| Dec 31, 2021 | 205.53 Mn |
| Sep 30, 2021 | 236.28 Mn |
API Access
CytomX Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();